COMMUNIQUÉS West-GlobeNewswire

Five Prime Therapeutics Submits Investigational New Drug Application for Novel B7-H4 Antibody FPA150
03/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]
Dova Pharmaceuticals Provides Update on Development Strategy for Avatrombopag in Immune Thrombocytopenic Purpura (ITP) and Chemotherapy-Induced Thrombocytopenia (CIT)
03/01/2018
Supplemental NDA for ITP to be submitted in the second half of 2018 Phase 3 Clinical Trial for CIT to begin in the second quarter of 2018 DURHAM, N.C., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Following two separate meetings [...]
GBT to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the 36 th Annual J.P. Morgan Healthcare Conference on Wednesday [...]
Five Prime Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]
Transparency notification pursuant to Article 14 of the Law of May 2, 2007
03/01/2018
REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 3, 2018, 22:00h CEST - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Nuvectra Announces Analyst & Investor Meeting at NANS 2018
03/01/2018
PLANO, Texas, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that the company will host an Analyst & Investor Meeting on Friday, [...]
Chimerix to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
DURHAM, N.C., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals to provide solutions to the growing population of immunocompromised patients, today [...]
Genesis HealthCare to Present at the 36th Annual J. P. Morgan Healthcare Conference on January 11, 2018
03/01/2018
KENNETT SQUARE, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare today announced that George V. Hager, Jr., Chief Executive Officer and Tom DiVittorio, Chief Financial Officer, will present at the 36 th Annual [...]
Achaogen to Present at J.P. Morgan Healthcare Conference
03/01/2018
– Company presentation scheduled for January 11, 2018 – SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative [...]
Teligent, Inc. to Present at the J.P. Morgan 36th Annual Healthcare Conference January 10th
03/01/2018
BUENA, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at the J.P. Morgan 36 th Annual Healthcare Conference. The [...]
Sharecare Appoints Ami Patel as Chief Legal and Compliance Officer
03/01/2018
ATLANTA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced it has named Ami Patel as the company’s chief legal and compliance [...]
Analogic to Present at Upcoming Investor Conferences
03/01/2018
PEABODY, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world’s medical imaging and aviation security technology, today announced that members of its management team will be [...]
OSE Immunotherapeutics Announces Appointment of Gérard Tardy as Chairman of Company’s Board of Directors
03/01/2018
NANTES, France, Jan. 03, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that the Company’s Board of Directors, meeting on January 3, 2018, has appointed Gérard Tardy as [...]
BriaCell Provides Clinical Update on its Lead Immunotherapy Drug in Advanced Breast Cancer
03/01/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Dyadic International Appoints New Board Member
03/01/2018
JUPITER, Fla., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the development and large-scale manufacture of low cost, better performing [...]
NICOX : Nombre de droits de vote au 31 décembre 2017
03/01/2018
Nicox SA Société anonyme au capital de 29 169 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 janvier 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
NICOX : Number of voting rights as of December 31, 2017
03/01/2018
Nicox SA Société anonyme with a registered capital of € 29,169,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On January 3, 2018, MONTHLY PUBLICATION OF THE [...]
UPDATE – Recro Pharma Announces Key Executive Promotions to the Financial Team
03/01/2018
MALVERN, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
NeuroMetrix to Present at Upcoming Biotech Showcase and Digital Medicine Showcase Conferences
03/01/2018
WALTHAM, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the 10 th Annual Biotech [...]

Pages